FluroTech (TSXV:TEST), (“FluroTech” or the “Company”), is pleased to announce the appointment of Dr. Trevor MacMillan as Director of Scientific Research and Business Development.
FluroTech (TSXV:TEST), (“FluroTech” or the “Company”), is pleased to announce the appointment of Dr. Trevor MacMillan as Director of Scientific Research and Business Development. With prior industry experience at Aurora Cannabis Inc., Dr. MacMillan brings with him an impressive background in plant breeding, biotechnology regulatory environments and quality control. He will be an integral part of FluroTech’s scientific and business development teams.
“Dr. MacMillan brings a unique perspective of the Licensed Producers’ needs in the realm of quality control, testing and analytics in the cannabis industry. With his depth of knowledge, we can better serve our customers as we bring our flagship product, CompleTestTM, to market this fall and biomarking technology in 2019,” commented Danny Dalla-Longa CEO of FluroTech.
“FluroTech has developed an elegant solution to simplify cannabis quality control testing. I’m excited about helping the cannabis industry produce safer, higher quality products with FluroTech’s technology. It’s a game changer,” stated Trevor. “Additionally, their biomarking technology represents a low cost and unique way to perform seed to sale product tracking that will solve the issues that exist with current solutions.”
Dr. MacMillan graduated from the University of Saskatchewan with a bachelor of science in biochemistry in 2001. In 2014, he completed his PhD in agricultural plant biotechnology at the University of Lethbridge. His postgraduate career began with Agriculture and Agri-Food Canada and Health Canada in waterborne photogene isolation and characterization. Following this period, Dr. MacMillan was previously employed by the Department of National Defence at Defence Research and Development Canada (DRDC) where he was instrumental in developing molecular detection assays for bacterial bio-threat agents. Additionally, he worked as the good laboratory practices (GLP) implementation co-ordinator for DRDC for a GLP-compliant facility performing regulatory drug studies. Later, he was employed by the Canadian Food Inspection Agency (CFIA) as a senior molecular research technologist. His most recent role at Aurora Cannabis Inc. as the Director of Research and Quality Control honed his knowledge of quality testing of cannabis.
FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech‘s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
Chief Executive Officer
IR — Thesis Capital Inc.